Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
Resource Type
Article
Authors
Gianni, Luca ; Dafni, Urania ; Gelber, Richard D ; Azambuja, Evandro ; Muehlbauer, Susanne ; Goldhirsch, Aron ; Untch, Michael ; Smith, Ian ; Baselga, José ; Jackisch, Christian ; Cameron, David ; Mano, Max ; Pedrini, José Luiz ; Veronesi, Andrea ; Mendiola, Cesar ; Pluzanska, Anna ; Semiglazov, Vladimir ; Vrdoljak, Eduard ; Eckart, Michael J ; Shen, Zhenzhou ; Skiadopoulos, George ; Procter, Marion ; Pritchard, Kathleen I ; Piccart-Gebhart, Martine J ; Bell, Richard
Source
In Lancet Oncology 2011 12(3):236-244
Subject
Primary Research Articles
Language
ISSN
1470-2045